{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:42:01Z","timestamp":1773114121762,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.bcp.2014.10.014","type":"journal-article","created":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T08:16:43Z","timestamp":1415348203000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated G\u03b2\u03b3 signaling"],"prefix":"10.1016","volume":"93","author":[{"given":"Tarsis F.","family":"Brust","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val J.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2014.10.014_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2014.10.014_bib0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2014.10.014_bib0015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molmed.2010.11.004","article-title":"Therapeutic potential of beta-arrestin- and G protein-biased agonists","volume":"17","author":"Whalen","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.bcp.2014.10.014_bib0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.bcp.2014.10.014_bib0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.pharmthera.2004.12.005","article-title":"Sensitization of adenylate cyclase by Galphai\/o-coupled receptors","volume":"106","author":"Watts","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2014.10.014_bib0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrd3430","article-title":"Priorities in Parkinson's disease research","volume":"10","author":"Meissner","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2014.10.014_bib0035","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.bcp.2014.10.014_bib0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/pr.107.00107","article-title":"Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection","volume":"60","author":"Lieberman","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bcp.2014.10.014_bib0045","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2174\/138161210790361461","article-title":"Third generation antipsychotic drugs: partial agonism or receptor functional selectivity","volume":"16","author":"Mailman","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bcp.2014.10.014_bib0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2850.2009.01373.x","article-title":"Partial agonists and schizophrenia: theoretical developments for the development of mental health nursing","volume":"16","author":"Jones","year":"2009","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"10.1016\/j.bcp.2014.10.014_bib0055","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.1073\/pnas.1104807108","article-title":"Discovery of beta-Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy","volume":"108","author":"Allen","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.10.014_bib0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors","volume":"302","author":"Burris","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2014.10.014_bib0065","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1124\/jpet.109.160598","volume":"331","author":"Fell","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2014.10.014_bib0070","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2014.10.014_bib0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.npp.1301071","article-title":"Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways","volume":"32","author":"Urban","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2014.10.014_bib0080","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","article-title":"Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes","volume":"20","author":"Lawler","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2014.10.014_bib0085","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.tips.2006.06.002","article-title":"Higher-order organization and regulation of adenylyl cyclases","volume":"27","author":"Cooper","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2014.10.014_bib0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/mol.52.2.181","article-title":"Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors","volume":"52","author":"Watts","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2014.10.014_bib0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/356159a0","article-title":"Hormonal-stimulation of adenylyl cyclase through gi-protein beta-gamma-subunits","volume":"356","author":"Federman","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2014.10.014_bib0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0898-6568(99)00084-4","article-title":"Regulation of adenylyl cyclase in the central nervous system","volume":"12","author":"Chern","year":"2000","journal-title":"Cell Signal"},{"key":"10.1016\/j.bcp.2014.10.014_bib0105","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1523\/JNEUROSCI.22-18-07931.2002","article-title":"Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase","volume":"22","author":"Lee","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2014.10.014_bib0110","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/nprot.2011.386","article-title":"Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells","volume":"6","author":"Schroder","year":"2011","journal-title":"Nat Protoc"},{"key":"10.1016\/j.bcp.2014.10.014_bib0115","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-2918(04)90066-5","article-title":"Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability","volume":"26","author":"DeLeon","year":"2004","journal-title":"Clin Therap"},{"key":"10.1016\/j.bcp.2014.10.014_bib0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/11538980-000000000-00000","article-title":"Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data","volume":"25","author":"Pae","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bcp.2014.10.014_bib0125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0920-9964(03)00050-1","article-title":"Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials","volume":"61","author":"Marder","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bcp.2014.10.014_bib0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1568007024606195","article-title":"Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis","volume":"1","author":"Tamminga","year":"2002","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.bcp.2014.10.014_bib0135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.lfs.2003.07.005","article-title":"The [35S]GTPgammaS binding assay: approaches and applications in pharmacology","volume":"74","author":"Harrison","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2014.10.014_bib0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrn2834","article-title":"Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease","volume":"11","author":"Luscher","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bcp.2014.10.014_bib0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00213-006-0468-2","article-title":"Repeated quinpirole treatments produce neurochemical sensitization and associated behavioral changes in female hamsters","volume":"188","author":"Chester","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bcp.2014.10.014_bib0150","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/sj.npp.1300483","article-title":"Repeated quinpirole treatment increases cAMP-dependent protein kinase activity and CREB phosphorylation in nucleus accumbens and reverses quinpirole-induced sensorimotor gating deficits in rats","volume":"29","author":"Culm","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2014.10.014_bib0155","doi-asserted-by":"crossref","first-page":"16027","DOI":"10.1073\/pnas.0807746105","article-title":"Transient and selective overexpression of D2 receptors in the striatum causes persistent deficits in conditional associative learning","volume":"105","author":"Bach","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.10.014_bib0160","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.neuron.2006.01.023","article-title":"Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning","volume":"49","author":"Kellendonk","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2014.10.014_bib0165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/syn.20303","article-title":"Psychosis pathways converge via D2high dopamine receptors","volume":"60","author":"Seeman","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.bcp.2014.10.014_bib0170","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0304-3940(90)90617-I","article-title":"Increased forskolin binding in the left parahippocampal gyrus and CA1 region in post mortem schizophrenic brain determined by quantitative autoradiography","volume":"118","author":"Kerwin","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bcp.2014.10.014_bib0175","first-page":"92","article-title":"Signal transduction abnormalities in schizophrenia: the cAMP system","volume":"36","author":"Muly","year":"2002","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.bcp.2014.10.014_bib0180","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1038\/srep03828","article-title":"Divergent label-free cell phenotypic pharmacology of ligands at the overexpressed beta(2)-adrenergic receptors","volume":"4","author":"Ferrie","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.bcp.2014.10.014_bib0185","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nbt.1671","article-title":"Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements","volume":"28","author":"Schroder","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bcp.2014.10.014_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2014.06.003","article-title":"What is pharmacological \u2018affinity\u2019? Relevance to biased agonism and antagonism","author":"Kenakin","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2014.10.014_bib0195","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1523\/JNEUROSCI.5074-06.2007","article-title":"Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo","volume":"27","author":"Beaulieu","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.bcp.2014.10.014_bib0200","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fnana.2011.00058","article-title":"Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia","volume":"5","author":"Del\u2019guidice","year":"2011","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.bcp.2014.10.014_bib0205","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.0803522105","article-title":"Antagonism of dopamine D2 receptor\/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics","volume":"105","author":"Masri","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.10.014_bib0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2007.11.041","article-title":"A beta-arrestin 2 signaling complex mediates lithium action on behavior","volume":"132","author":"Beaulieu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2014.10.014_bib0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"Caron M. An Akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"Beaulieu","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2014.10.014_bib0220","doi-asserted-by":"crossref","first-page":"20732","DOI":"10.1073\/pnas.1215489109","article-title":"Deletion of GSK3beta in D2R-expressing neurons reveals distinct roles for beta-arrestin signaling in antipsychotic and lithium action","volume":"109","author":"Urs","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2014.10.014_bib0225","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1021\/jm300603y","article-title":"Structure-functional selectivity relationship studies of beta-arrestin-biased dopamine D(2) receptor agonists","volume":"55","author":"Chen","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2014.10.014_bib0230","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1124\/pr.111.005603","article-title":"The expanding roles of Gbetagamma subunits in G protein-coupled receptor signaling and drug action","volume":"65","author":"Khan","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bcp.2014.10.014_bib0235","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1124\/mol.111.073072","article-title":"Understanding molecular recognition by G protein betagamma subunits on the path to pharmacological targeting","volume":"80","author":"Lin","year":"2011","journal-title":"Mol Pharmacol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214006327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295214006327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T03:57:53Z","timestamp":1566014273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295214006327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0006295214006327"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2014.10.014","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated G\u03b2\u03b3 signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2014.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}